Amgen strikes outcomes-based payment plan for Enbrel with Ab...

Pharmacy benefit manager Abarca has announced a US reimbursement contract with Amgen for its Enbrel (etanercept) inflammatory diseases drug that will see rebates issued should patients stop

ViiV presses go on FDA filing for first-in-class HIV drug fo...

US eyes faster launch for biosimilars in North American trad...

Senate committee backs Hahn as new FDA Commissioner

FDA sets January action date for Keytruda in early bladder c...

ABPI looks internally for new CEO, naming Richard Torbett